Skip to content
BiologicalX

Comparison

Creatine Monohydrate vs Sermorelin

Side-by-side of Creatine Monohydrate and Sermorelin. Every row below is pulled from the compound schema and will update as our data grows. For deeper reads, follow through to each compound page.

Effects at a glance

Creatine Monohydrate

  • Increases anaerobic strength and power output by ~5 to 15% across multiple training studies
  • Adds ~1 to 2 kg of lean body mass over 4 to 12 weeks, partly intracellular water and partly true tissue gain
  • Improves 1-rep max on bench and squat by ~5 to 10% versus placebo in resistance-trained adults
  • Cognitive benefit appears mainly under sleep deprivation or high mental load, less so in well-rested individuals
  • Saturation reached in ~28 days at 3 to 5 g/day, or ~5 to 7 days with a 20 g/day loading phase
  • No evidence of renal harm in healthy adults across long-term studies; caution in pre-existing severe renal disease

Sermorelin

  • Synthetic 29-amino-acid GHRH fragment; FDA approved 1997 for pediatric GH deficiency as Geref
  • Voluntarily discontinued by Serono in 2008 for commercial reasons; not safety-related
  • Compounded by 503A/503B pharmacies for off-label adult anti-aging and body-composition use
  • Produces physiologic pulsatile GH release; ~10 to 20 minute plasma half-life
  • Standard anti-aging clinic protocol: 200 to 500 mcg subcutaneously pre-bed, often with ipamorelin
  • Banned by WADA under S2 (peptide hormones, growth factors)

Side-by-side

Attribute Creatine Monohydrate Sermorelin
Category supplement peptide
Also known as creatine Sermorelin acetate, GRF 1-29, Geref, GHRH (1-29) NH2
Half-life (hr) 3 0.25
Typical dose (mg) 5000 0.3
Dosing frequency daily 1-2x daily
Routes oral subcutaneous
Onset (hr) 168 0.25
Peak (hr) - 0.5
Molecular weight 149.15 3357.88
Molecular formula C4H9N3O2 C149H246N44O42S
Mechanism Donates a phosphate group to ADP via creatine kinase, regenerating ATP during high-intensity, short-duration efforts. Synthetic 29-amino-acid GHRH fragment that binds the GHRH receptor on pituitary somatotrophs to stimulate endogenous pulsatile GH synthesis and release while preserving the GH-IGF-1 negative feedback loop.
Legal status Dietary supplement (most jurisdictions) FDA approved 1997 (Geref, pediatric GHD); voluntarily discontinued by Serono 2008; compounded by 503A/503B pharmacies for off-label adult use; banned by WADA
WADA status allowed banned
DEA / Rx OTC supplement Rx only via compounding (no controlled-substance schedule)
Pregnancy Insufficient data Category C (historical labeling); not recommended in pregnancy
CAS 57-00-1 86168-78-7
PubChem CID 586 16129617
Wikidata Q408389 Q416620

Safety profile

Creatine Monohydrate

Common side effects

  • water retention
  • mild GI upset at loading doses
  • weight gain (2 to 4 lb from intracellular water)

Contraindications

  • severe renal impairment

Interactions

  • caffeine (high-dose acute): mixed data on ergogenic interference; chronic use appears compatible(minor)
  • nephrotoxic drugs (NSAIDs, cyclosporine): theoretical additive renal strain in at-risk patients(moderate)

Sermorelin

Common side effects

  • injection-site pain or irritation
  • transient flushing
  • headache
  • vivid dreams (pre-bed dosing)

Contraindications

  • pregnancy
  • active malignancy
  • history of pituitary tumor
  • diabetic retinopathy (theoretical)
  • untreated hypothyroidism

Interactions

  • ipamorelin: synergistic GH release via parallel GHRH and ghrelin pathways; standard anti-aging clinic pairing(minor)
  • CJC-1295: pharmacologically redundant (both GHRH-pathway); typically not stacked(minor)
  • insulin: sustained GH can blunt insulin sensitivity over weeks(moderate)
  • corticosteroids: blunt GH response; reduce expected efficacy(moderate)
  • levothyroxine (untreated hypothyroidism): untreated hypothyroidism blunts GH response; correct thyroid first(moderate)

Which Should You Take?

Creatine Monohydrate comes out ahead for most readers on the criteria we weight: 3 catalogued goals, OTC dietary supplement, oral dosing, with a Tier-A outcome catalogued. Sermorelin is the right call when one of the conditionals below applies.

Edge case: If you want to avoid FDA approved 1997 (Geref, pediatric GHD); voluntarily discontinued by Serono 2008; compounded by 503A/503B pharmacies for off-label adult use; banned by WADA, Creatine Monohydrate is the more accessible choice.

Default choice: Creatine Monohydrate. Lower friction to source, a Tier-A evidence outcome catalogued, and broader goal coverage. Reach for Sermorelin only if your priority sits squarely in the goals it owns above.

This verdict is generated from each compound's schema (goals, legal status, evidence outcomes, dosing route). It updates automatically as our compound data evolves; the deeper read sits on each individual compound page.

Common questions

What is the difference between Creatine Monohydrate and Sermorelin?

Creatine Monohydrate and Sermorelin differ in category (supplement vs peptide), mechanism, and typical dosing. See the side-by-side table for full details.

Which has a longer half-life, Creatine Monohydrate or Sermorelin?

Creatine Monohydrate half-life is 3 hours; Sermorelin half-life is 0.25 hours.

Can you stack Creatine Monohydrate with Sermorelin?

Stack compatibility depends on mechanism overlap, legal status, and individual response. Check each compound page for specific interactions and contraindications before combining.

Go deeper